Altered antigen presentation in mice lacking H2-O.

[1]  J. Austyn.  Antigen-presenting cells. Experimental and clinical studies of dendritic cells. , 2000, American journal of respiratory and critical care medicine.

[2]  P. Cresswell,et al.  Negative regulation by HLA-DO of MHC class II-restricted antigen processing. , 1997, Science.

[3]  P. A. Peterson,et al.  Antigen specificity of dual reactive T hybridomas determines the requirement for CD40 ligand-CD40 interactions. , 1997, Journal of Immunology.

[4]  D. Douek,et al.  HLA-DO is an intracellular class II molecule with distinctive thymic expression. , 1997, International immunology.

[5]  G. Hämmerling,et al.  How HLA-DM edits the MHC class II peptide repertoire: survival of the fittest? , 1997, Immunology today.

[6]  F. Sallusto,et al.  Origin, maturation and antigen presenting function of dendritic cells. , 1997, Current opinion in immunology.

[7]  C. Watts,et al.  Capture and processing of exogenous antigens for presentation on MHC molecules. , 1997, Annual review of immunology.

[8]  B. Evavold,et al.  Enhanced Dissociation of HLA-DR-Bound Peptides in the Presence of HLA-DM , 1996, Science.

[9]  M. Jackson,et al.  HLA‐DO is a lysosomal resident which requires association with HLA‐DM for efficient intracellular transport. , 1996, The EMBO journal.

[10]  P. A. Peterson,et al.  Antigen Presentation and T Cell Development in H2-M-Deficient Mice , 1996, Science.

[11]  C. Benoist,et al.  Mice Lacking H2-M Complexes, Enigmatic Elements of the MHC Class II Peptide-Loading Pathway , 1996, Cell.

[12]  H. Ruley,et al.  H2-M Mutant Mice Are Defective in the Peptide Loading of Class II Molecules, Antigen Presentation, and T Cell Repertoire Selection , 1996, Cell.

[13]  P. Jensen,et al.  A structural transition in class II major histocompatibility complex proteins at mildly acidic pH , 1996, The Journal of experimental medicine.

[14]  N. Allbritton,et al.  Evidence for a conformational change in a class II major histocompatibility complex molecule occurring in the same pH range where antigen binding is enhanced , 1996, The Journal of experimental medicine.

[15]  J. Sprent,et al.  Antigen-Presenting Cells: Professionals and amateurs , 1995, Current Biology.

[16]  D. Weber,et al.  DM enhances peptide binding to class II MHC by release of invariant chain-derived peptide. , 1995, Immunity.

[17]  P. Cresswell,et al.  HLA-DM induces clip dissociation from MHC class II αβ dimers and facilitates peptide loading , 1995, Cell.

[18]  D. Zaller,et al.  Mediation by HLA-DM of dissociation of peptides from HLA-DR , 1995, Nature.

[19]  A. Lanzavecchia,et al.  Modulation of antigen processing by bound antibodies can boost or suppress class II major histocompatibility complex presentation of different T cell determinants , 1995, The Journal of experimental medicine.

[20]  R. Mitchell,et al.  Intracellular targeting of antigens internalized by membrane immunoglobulin in B lymphocytes , 1995, The Journal of experimental medicine.

[21]  H. Ploegh,et al.  How MHC class II molecules acquire peptide cargo: biosynthesis and trafficking through the endocytic pathway. , 1995, Annual review of cell and developmental biology.

[22]  P. A. Peterson,et al.  Reconstitution of an operational MHC class II compartment in nonantigen-presenting cells. , 1994, Science.

[23]  J. Trowsdale,et al.  Accumulation of HLA-DM, a regulator of antigen presentation, in MHC class II compartments. , 1994, Science.

[24]  H. Geuze,et al.  Human resident langerhans cells display a lysosomal compartment enriched in MHC class II. , 1994, The Journal of investigative dermatology.

[25]  J. Neefjes,et al.  Major histocompatibility complex class II molecules induce the formation of endocytic MIIC-like structures , 1994, The Journal of cell biology.

[26]  C. Watts,et al.  Antigen processing and class II MHC peptide-loading compartments in human B-lymphoblastoid cells , 1994, Nature.

[27]  H. Ploegh,et al.  Isolation and characterization of the intracellular MHC class II compartment , 1994, Nature.

[28]  I. Mellman,et al.  Transient accumulation of new class II MHC molecules in a novel endocytic compartment in B lymphocytes , 1994, Nature.

[29]  B. Arp,et al.  HLA-DMA and -DMB genes are both required for MHC class II/peptide complex formation in antigen-presenting cells , 1994, Nature.

[30]  Jeffrey A. Shaman,et al.  An essential role for HLA–DM in antigen presentation by class II major histocompatibility molecules , 1994, Nature.

[31]  M. Jackson,et al.  Empty and peptide-containing conformers of class I major histocompatibility complex molecules expressed in Drosophila melanogaster cells. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[32]  M R Jackson,et al.  In vitro peptide binding to soluble empty class I major histocompatibility complex molecules isolated from transfected Drosophila melanogaster cells. , 1992, The Journal of biological chemistry.

[33]  J. Sprent,et al.  Two subsets of epithelial cells in the thymic medulla , 1992, The Journal of experimental medicine.

[34]  D. Wiley,et al.  The human class II MHC protein HLA-DR1 assembles as empty αβ heterodimers in the absence of antigenic peptide , 1992, Cell.

[35]  P. Jensen,et al.  Enhanced binding of peptide antigen to purified class II major histocompatibility glycoproteins at acidic pH , 1991, The Journal of experimental medicine.

[36]  P. A. Peterson,et al.  A novel class II MHC molecule with unusual tissue distribution , 1991, Nature.

[37]  H. Geuze,et al.  Segregation of MHC class II molecules from MHC class I molecules in the Golgi complex for transport to lysosomal compartments , 1991, Nature.

[38]  W. Lee,et al.  Memory B and T cells. , 1991, Annual review of immunology.

[39]  J. Sprent,et al.  Induction of neonatal tolerance to Mlsa antigens by CD8+ T cells. , 1990, Science.

[40]  B. Arp,et al.  Defective processing and presentation of exogenous antigens in mutants with normal HLA class II genes , 1990, Nature.

[41]  C. Pinkert,et al.  Transgenic mice with mu and kappa genes encoding antiphosphorylcholine antibodies , 1986, The Journal of experimental medicine.

[42]  R. Jemmerson,et al.  Mapping epitopes on a protein antigen by the proteolysis of antigen-antibody complexes. , 1986, Science.

[43]  Eric O Long,et al.  DO beta: a new beta chain gene in HLA‐D with a distinct regulation of expression. , 1985, The EMBO journal.

[44]  R. Flavell,et al.  Multiple mechanisms regulate the expression of murine immune response genes , 1985, Cell.

[45]  Antonio Lanzavecchia,et al.  Antigen-specific interaction between T and B cells , 1985, Nature.

[46]  K. Rock,et al.  Antigen presentation by hapten-specific B lymphocytes. I. Role of surface immunoglobulin receptors , 1984, The Journal of experimental medicine.

[47]  T. Springer,et al.  A shared alloantigenic determinant on Ia antigens encoded by the I-A and I-E subregions: evidence for I region gene duplication. , 1981, Journal of immunology.

[48]  F. Celada,et al.  Antibody-mediated activation of genetically defective Escherichia coli beta-galactosidases by monoclonal antibodies produced by somatic cell hybrids. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[49]  B. B. Mishell,et al.  Selected Methods in Cellular Immunology , 1980 .

[50]  N H Sigal,et al.  Heterogeneity of the BALB/c antiphosphorylcholine antibody response at the precursor cell level , 1975, The Journal of experimental medicine.

[51]  L. Stryer,et al.  Fluorescence spectroscopy of proteins. , 1968, Science.